Reaktionsgleichung
[C:1]([O:5][C:6](=[O:26])[NH:7][C@H:8]1[CH2:12][CH2:11][N:10](CC2C=C3C(C=CN=C3N)=CC=2)[C:9]1=[O:25])([CH3:4])([CH3:3])[CH3:2].[NH2:27][C:28]1[C:33]2[CH:34]=[C:35]([CH2:37][NH2:38])[O:36][C:32]=2[CH:31]=[CH:30][N:29]=1>>[C:1]([O:5][C:6](=[O:26])[NH:7][C@H:8]1[CH2:12][CH2:11][N:10]([NH:38][CH2:37][C:35]2[O:36][C:32]3[CH:31]=[CH:30][N:29]=[C:28]([NH2:27])[C:33]=3[CH:34]=2)[C:9]1=[O:25])([CH3:2])([CH3:3])[CH3:4]Komponenten
3
Versuchsvorschrift
Using the procedure described in example 85i 166 mg of 4-amino-2-(aminomethyl)furo[3,2-c]pyridine was transformed into 150 mg of the title compound. MS ESI+: 347 (M+H).
Quellen und Nachweise
- ORD-Eintrag
- ord-f08d66aaf2734f7f8b7e49868a753248
- Quelldatensatz
- uspto-grants-2004_09
- Patentnummer
- US06797710B2
Verknüpfte Notizen
Wird geladen…